Abzena hosts first Biopharmaceutical Discovery and Development Symposium and open day at Cambridge, UK site

Cambridge, UK, 26 April 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, is today hosting its first Biopharmaceutical Discovery and Development Symposium and open day, showcasing its new facility at the Babraham Research Campus in Cambridge, UK.

The Symposium will highlight the latest technologies and advancements in the biopharmaceutical discovery and development field by Abzena and its partners, and how these have been successfully used by drug developers to create biopharmaceuticals to address significant unmet medical needs. External speakers will include representatives from UCL, ImCheck Therapeutics, Sartorius Stedim Biotech and UGA Biopharma.

There will also be tours of Abzena’s new state-of-the-art laboratories used in discovery, immunology, bioassays, protein engineering, bioconjugation, bioanalytics and cell line development to showcase the contribution of these scientific groups within Abzena to the biopharmaceutical discovery and development process.